Xofluza (baloxavir marboxil)

Xofluza (baloxavir marboxil) is indicated for the treatment acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.

This product is currently out of stock and unavailable.

SKU: N/A Categories: ,

Xofluza (baloxavir marboxil) is indicated for the treatment acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

Approved presentations:

20 mg in packs containing 2 or 4 tablets
40 mg in packs containing 1 or 2 tablets

Please see full prescribing information and available presentations at:

[1] Prescribing Information (FDA): Xofluza (baloxavir marboxil)  [PDF], Novartis, October 2018.

Please note that this medicine may have also been approved in other regions than the ones we’ve listed. If you have a question about it’s approval in a specific country feel free to contact our support team.

Tablets

2 tablets of 20 mg, 4 tablets of 20 mg, 1 tablet of 40 mg, 2 tablets of 40 mg